Correlation Between Forte Biosciences and Theriva Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Theriva Biologics, you can compare the effects of market volatilities on Forte Biosciences and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Theriva Biologics.

Diversification Opportunities for Forte Biosciences and Theriva Biologics

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Forte and Theriva is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Theriva Biologics go up and down completely randomly.

Pair Corralation between Forte Biosciences and Theriva Biologics

Given the investment horizon of 90 days Forte Biosciences is expected to generate 1.67 times more return on investment than Theriva Biologics. However, Forte Biosciences is 1.67 times more volatile than Theriva Biologics. It trades about 0.14 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.14 per unit of risk. If you would invest  709.00  in Forte Biosciences on September 17, 2024 and sell it today you would earn a total of  1,217  from holding Forte Biosciences or generate 171.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Forte Biosciences  vs.  Theriva Biologics

 Performance 
       Timeline  
Forte Biosciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Theriva Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theriva Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Forte Biosciences and Theriva Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Forte Biosciences and Theriva Biologics

The main advantage of trading using opposite Forte Biosciences and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.
The idea behind Forte Biosciences and Theriva Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios